Back to Authors

Shwaartz, Chaya

https://orcid.org/0000-0003-2841-9834

Mayo Clinic

University Health Network

Citations 3

Beyond boundaries: An exploration of general surgery education in Canada and India
Patel, Prachikumari , Ray, Samrat, Coe, Taylor M. , Shwaartz, Chaya , Ray, Samrat , Rajendran, Luckshi , Muaddi, Hala , Irfan, Ahmer

Current Medicine Research and Practice | October 30, 2024 | Volume: 14 | Issue: 5 | Pages: 214-221

10.4103/cmrp.cmrp_110_24 Get It

ABSTRACT General surgery is a dynamic and multifaceted field influenced by diverse factors, ranging from cultural norms to healthcare system structures and technological advancements. This review paper delves into a comparative exploration of the educational landscapes in Canada and India, unravelling the intricacies of training aspiring general surgeons. As two nations with distinct healthcare systems and educational frameworks, Canada and India offer unique perspectives on the journey from medical school to independent surgical practice. This article compares the residency application process, training structure, assessment methods, challenges faced during clinical training and the role of research in surgical programmes between the two nations. Through this comparative lens, we seek to provide valuable insights that may inform future developments in surgical education, fostering a global exchange of knowledge and practices to advance healthcare systems worldwide.
Dynamic risk profiling of HCC recurrence after curative intent liver resection
Ivanics, Tommy , Perez, Carla , Claasen, Marco P. A. W. , Patel, Madhukar S. , Morgenshtern, Gabriela , Erdman, Lauren , Shwaartz, Chaya , Rajendran, Luckshi , O’Kane, Grainne M. , Murillo Perez, Carla Fiorella , Hansen, Bettina E. , Cleary, Sean P , Sapisochin, Gonzalo , Ivanics, Tommy , Cleary, Sean P. , Sapisochín, Gonzalo , Patel, Madhukar , O'Kane, Grainne M.

Hepatology | February 18, 2022 | Volume: 76 | Issue: 5 | Pages: 1291-1301

10.1002/hep.32411 Get It

Abstract Background and Aims Following liver resection (LR) for HCC, the likelihood of survival is dynamic, in that multiple recurrences and/or metastases are possible, each having variable impacts on outcomes. We sought to evaluate the natural progression, pattern, and timing of various disease states after LR for HCC using multistate modeling and to create a practical calculator to provide prognostic information for patients and clinicians. Approach and Results Adult patients undergoing LR for HCC between January 2000 and December 2018 were retrospectively identified at a single center. Multistate analysis modeled post‐LR tumor progression by describing transitions between distinct disease states. In this model, the states included surgery, intrahepatic recurrence (first, second, third, fourth, fifth), distant metastasis with or without intrahepatic recurrence, and death. Of the 486 patients included, 169 (34.8%) remained recurrence‐free, 205 (42.2%) developed intrahepatic recurrence, 80 (16.5%) developed distant metastasis, and 32 (7%) died. For an average patient having undergone LR, there was a 33.1% chance of remaining disease‐free, a 31.0% chance of at least one intrahepatic recurrence, a 16.3% chance of distant metastasis, and a 19.8% chance of death within the first 60 months post‐LR. The transition probability from surgery to first intrahepatic recurrence, without a subsequent state transition, increased from 3% (3 months) to 17.4% (30 months) and 17.2% (60 months). Factors that could modify these probabilities included tumor size, satellite lesions, and microvascular invasion. The online multistate model calculator can be found on https://multistatehcc.shinyapps.io/home/. Conclusions In contrast to standard single time‐to‐event estimates, multistate modeling provides more realistic prognostication of outcomes after LR for HCC by taking into account many postoperative disease states and transitions between them. Our multistate modeling calculator can provide meaningful data to guide the management of patients undergoing postoperative surveillance and therapy.
Perihilar Cholangiocarcinoma – Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers
Breuer, Eva , Mizuno, Takashi , Bartsch, F. , Ratti, Francesca , Benzing, Christian , Ammar-Khodja, Noémie, Sugiura, Teiichi , Takayashiki, Tsukasa , Hessheimer, Amelia J. , Kim, Hyung Sun , Ahn, Keun Soo , Wong, Tiffany , D’Silva, Mizelle , Koerkamp, Bas Groot , Jeddou, Heithem , Ponthaud, Charles de , Ismail, Warsan, Nooijen, Lynn E. , Hidalgo-Salinas, Camila, Wagner, Kim C. , Gunasekaran, Ganesh , Higuchi, Ryota , Gleisner, Ana , Shwaartz, Chaya , Schulick, Richard D. , Yamamoto, Masakazu , Schwartz, Myron , Oldhafer, Karl J. , Prachalias, Andreas , Fusai, Giuseppe , Erdmann, Joris I. , Line, Pål‐Dag , Smoot, Rory L. , Robles, R , Boudjéma, Karim , Polak, Wojciech G. , Neumann, Ulf P. , Lo, Chung‐Mau, Kang, Koo Jeong , Park, Joon Seong , Fondevila, Constantino , Uesaka, Katsuhiko , Pratschke, Johann , Aldrighetti, Luca , Oliveira, Michelle, Lang, Hauke , Nagino, Masato , Clavien, Pierre‐Alain , Yonkus, Jennifer A. , Line, Pål Dag , Smoot, Rory L , Aldrighetti, Luca , Erdmann, Joris I , Polak, Wojciech G , Wong, Tiffany C L , De Ponthaud, Charles , Groot Koerkamp, Bas , Ratti, Francesca , Mueller, Matteo , Kim, Hyung Sun, Ruzzenente, Andrea , Ahn, Keun Soo, Wong, Tiffany, Bednarsch, Jan , Jeddou, Heithem, Lopez-Lopez, Víctor; https://orcid.org/0000-0003-1718-3352, Kontis, Elissaios A. , Higuchi, Ryota, al, et, Schulick, Richard D., Yamamoto, Masakazu, Noji, Takehiro , Hirano, Satoshi, Schwartz, Myron, Oldhafer, Karl J., Fusai, Giuseppe K., Soubrane, Olivier , Polak, Wojciech G.; id_orcid 0000-0002-3096-4893, Han, Ho Seong, Neumann, Ulf P., Lo, Chung Mau , Guglielmi, Alfredo , Ohtsuka, Masayuki , Adam, René, Pratschke, Johann, Oliveira, Michelle L. De, Gores, Gregory J.

Annals of Surgery | August 2, 2021 | Volume: 274 | Issue: 5 | Pages: 780-788

10.1097/sla.0000000000005103 Get It

Objective: The aim of this study was to define robust benchmark values for the surgical treatment of perihilar cholangiocarcinomas (PHC) to enable unbiased comparisons. Background: Despite ongoing efforts, postoperative mortality and morbidity remains high after complex liver surgery for PHC. Benchmark data of best achievable results in surgical PHC treatment are however still lacking. Methods: This study analyzed consecutive patients undergoing major liver surgery for PHC in 24 high-volume centers in 3 continents over the recent 5-year period (2014–2018) with a minimum follow-up of 1 year in each patient. Benchmark patients were those operated at high-volume centers (≥50 cases during the study period) without the need for vascular reconstruction due to tumor invasion, or the presence of significant co-morbidities such as severe obesity (body mass index ≥35), diabetes, or cardiovascular diseases. Benchmark cutoff values were derived from the 75th or 25th percentile of the median values of all benchmark centers. Results: Seven hundred eight (39%) of a total of 1829 consecutive patients qualified as benchmark cases. Benchmark cut-offs included: R0 resection ≥57%, postoperative liver failure (International Study Group of Liver Surgery): ≤35%; in-hospital and 3-month mortality rates ≤8% and ≤13%, respectively; 3-month grade 3 complications and the CCI: ≤70% and ≤30.5, respectively; bile leak-rate: ≤47% and 5-year overall survival of ≥39.7%. Centers operating mostly on complex cases disclosed better outcome including lower post-operative liver failure rates (4% vs 13%; P = 0.002). Centers from Asia disclosed better outcomes. Conclusion: Surgery for PHC remains associated with high morbidity and mortality with now the availability of benchmark values covering 21 outcome parameters, which may serve as key references for comparison in any future analyses of individuals, group of patients or centers.